France Foundation - PROTECT™

Participate in the PROTECT™ Adolescent Immunization Performance Improvement-CME activity in MedConcert.com®

Activity Information:

Date of Original Release: August 1, 2011
Date of Most Recent Review/Update: January 2014
AMA PRA Category 1 Credits™ Termination/Expiration Date: June 30, 2015
ABP MOC Termination/Expiration Date: July 14, 2017
AOA Category 1-B CAP Termination/Expiration Date: December 31, 2016
AAPA Category 1 PI-CME Credits Termination/Expiration Date: June 30, 2015

Fee: There is a $150.00 fee for participating in this activity.

Target Audience: Health care professionals who manage immunizations including:

	Family Physicians
	Pediatricians
	Physician Assistants

PROTECT™ Educational Initiative Faculty (Associated with the original launch, August 2011)

Theodore Bruno, MD Chief Medical Officer The France Foundation	Gary S. Marshall, MD Chief, Division of Pediatric Infectious Disease Professor of Pediatrics Director, Pediatric Clinical Trials Unit University of Louisville School of Medicine
Doug Campos-Outcalt, MD, MPA (Chairperson) Associate Chair and Clinical Professor Department of Family and Community Medicine Assistant Dean for Outreach and Multicultural Affairs University of Arizona College of Medicine, Phoenix Campus Associate Professor of University of Arizona College of Public Health	Sharon McGill, MPH Director, Department of Quality and Research American Osteopathic Association
Stanley A. Gall, MD Professor, Obstetrics, Gynecology and Women's Health University of Louisville	Kristin L. Nichol, MD, MPH, MBA Professor of Medicine University of Minnesota Medical School Associate Chief of Staff for Research Minneapolis VA Medical Center
Stanley E. Grogg, DO, FACOP, FAAP Interim President and Dean Professor of Pediatrics Oklahoma State University Center for Health Sciences
Faculty Review of Performance Improvement Activity Updates January 2014
Stanley E. Grogg, DO, FACOP, FAAP Associate Dean of Clinical Research and Medical Director of Service Learning Professor of Pediatrics Oklahoma State University Center for Health Sciences	Marie-Michèle Léger, MPH, PA-C Director, Clinical Education American Academy of Physician Assistants 2318 Mill Road Suite 1300 Alexandria, VA 22314

RESOLUTION OF CONFLICTS OF INTEREST
In accordance with the ACCME Standards for Commercial Support of CME, the University of Nebraska Medical Center, Center for Continuing Education will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

DISCLOSURE
It is the policy of the University of Nebraska Medical Center, Center for Continuing Education to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The University of Nebraska Medical Center, Center for Continuing Education has identified and resolved any and all conflicts of interest prior to the release of this activity.

Activity Staff Disclosures

The following planners, reviewers, editors, staff, CME committee, or other members who control content have indicated they have no relationships with industry to disclose relative to the content of this CME activity:

The planners, reviewers, editors, staff, CME committee, or other members at the University of Nebraska Medical Center, Center for Continuing Education, The France Foundation, AAPA, and AOA who control content have no relevant financial relationships to disclose.

Faculty Disclosures

The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME activity:

	Dr. Doug Campos-Outcalt has received honoraria from Faces of Flu.
	Dr. Stanley Gall has received grants/research support from GlaxoSmithKline and Merck, and has served as a consultant for Merck. He has received honoraria from GlaxoSmithKline and Merck.
	Dr. Stanley Grogg has received grants/research support from GlaxoSmithKline, MedImmune, Merck, Novartis, Pfizer, and Sanofi. He has also served as a consultant for Merck and Novartis, and received honoraria from Merck, Novartis, Sanofi, GlaxoSmithKline, Pfizer, and MedImmune.
	Dr. Gary Marshall has received grants/research support from and served as a consultant for GlaxoSmithKline, Merck, Novartis, and Sanofi.
	Dr. Amy Middleman has received grants/research support from MedImmune and Sanofi.
	Dr. Kristin Nichol has served as a consultant for CSL, GlaxoSmithKline, MedImmune, Merck, Novartis, Sanofi, and Wyeth.
	Dr. Richard Zimmerman (American Academy of Family Physicians) has served as a consultant for MedImmune, received honoraria from MedImmune, and received research grants/support from MedImmune, Merck, and Sanofi.

UNAPPROVED USE DISCLOSURE
The University of Nebraska Medical Center, Center for Continuing Education requires CME faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity was originally (August 2011) supported by educational grants from GlaxoSmithKline and Pfizer, Inc. The current activity is not supported by any educational grants.

DISCLAIMER
The University of Nebraska Medical Center, Center for Continuing Education presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care.

Purpose and Learning Objectives:

This activity has been developed to provide education and strategies to minimize knowledge gaps and improve performance in the area of vaccine-preventable diseases. At the conclusion of the activity, participants will be able to:

	Acknowledge the indications and recommendations for current vaccines and vaccine schedules across adolescent populations
	Address immunization barriers frequently encountered during patient/caregiver communications regarding safety, efficacy, and possible misinformation
	Implement strategies for improving immunization rates within one’s clinical practice, taking into account current immunization schedules and guidelines

Estimated Time to Complete the Educational Activity:
This PI CME activity should take approximately 1-6 months to complete in its entirety. For completion of both Stage A and Stage C, data from 10 patient charts are required and the time frame for completion will vary based on patient caseload/sufficient time to accumulate patient records.

For ABP Diplomates ONLY:
This PIM requires you to collect and report immunization rates on a total of 30 unique patient records to assess your performance improvement efforts at providing immunizations for adolescents. You must be an actively practicing physician with a sufficient number of adolescent patients (target age of 13 years old) to report your data and complete this PIM’s baseline and two assessment cycles, and to be eligible for MOC credit with ABP.

The baseline cycle in Stage A requires you to collect and report information on 10 patient records.

Stage B then offers a variety of educational resources and tools for your practice to develop and implement an improvement strategy for your immunization rates.

Stage C requires you to collect and report information on 10 different patient records. These data should be from patients you have seen in your practice after you entered Stage B. The reason for this is because you need sufficient time to implement changes in your practice and for those changes to take affect so you may see the results of your efforts. Your results will be presented in comparison to your performance in Stage A (your baseline assessment). At this time, you may reflect on your results and make additional changes to your practice to assist you in further improving immunizations rates for your patients.

The next improvement cycle requires you to collect and report information on 10 different patient records. The results of these data will be presented in comparison to your performance in the first cycle of Stage C. While there is no waiting period between Stage C and your data submission for the next set of 10 patient records, we do recommend that you allow sufficient time to implement changes in your practice and for those changes to take effect so you may see the results of your efforts at performance improvement.

Upon completion of this PIM, your information will be sent to ABP for MOC credit. Please allow 30 business days for UNMC to submit your completion data to ABP.

Accreditation Statement:
The University of Nebraska Medical Center, Center for Continuing Education, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Nebraska Medical Center, Center for Continuing Education, designates this PI CME activity for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is sponsored by the American Osteopathic Association of Medical Informatics, an AOA-accredited CME Sponsor. The Council on Continuing Medical Education of the American Osteopathic Association has approved this activity for 20 credits of AOA Category 1-B credit.

This activity is approved by the American Board of Pediatrics as a Part 4 activity for 20 (twenty) Maintenance of Certification (MOC) points.

Please note: You must complete this Performance Improvement Activity in its entirety to be eligible for MOC Part 4 credit.

This Performance Improvement CME program has been reviewed and is approved for a maximum of 20 AAPA Category 1 PI-CME credits by the Physician Assistant Review Panel. All stages of the activity must be completed for a participant to claim any credit. Approval is valid until June 30, 2015. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity. This program was planned in accordance with AAPA’s CME Standards.